Shanghai Kaibao Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -29.28% vs -15.75% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -23.07% vs -4.76% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "283.30",
          "val2": "400.60",
          "chgp": "-29.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "69.10",
          "val2": "101.70",
          "chgp": "-32.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.20",
          "val2": "-2.90",
          "chgp": "58.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "64.70",
          "val2": "84.10",
          "chgp": "-23.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "244.00%",
          "val2": "231.70%",
          "chgp": "1.23%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -21.63% vs -7.56% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -25.85% vs 14.68% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,140.70",
          "val2": "1,455.60",
          "chgp": "-21.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "301.00",
          "val2": "388.70",
          "chgp": "-22.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.10",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-10.70",
          "val2": "1.10",
          "chgp": "-1,072.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "278.00",
          "val2": "374.90",
          "chgp": "-25.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "232.60%",
          "val2": "242.10%",
          "chgp": "-0.95%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

283.30

400.60

-29.28%

Operating Profit (PBDIT) excl Other Income

69.10

101.70

-32.06%

Interest

0.00

0.00

Exceptional Items

-1.20

-2.90

58.62%

Consolidate Net Profit

64.70

84.10

-23.07%

Operating Profit Margin (Excl OI)

244.00%

231.70%

1.23%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -29.28% vs -15.75% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -23.07% vs -4.76% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,140.70

1,455.60

-21.63%

Operating Profit (PBDIT) excl Other Income

301.00

388.70

-22.56%

Interest

0.20

0.10

100.00%

Exceptional Items

-10.70

1.10

-1,072.73%

Consolidate Net Profit

278.00

374.90

-25.85%

Operating Profit Margin (Excl OI)

232.60%

242.10%

-0.95%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -21.63% vs -7.56% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -25.85% vs 14.68% in Dec 2024

All Annual Results